EU VC Podcast: Sergey Jakimov on longevity investing

It’s a comment we often hear as a longevity VC – what does investing in longevity actually mean? You should know that our goal isn't to cure aging with a single pill or treatment. Instead, we look at areas like personalized oncology, diagnostics and epigenetic reprogramming to fight aging and prevent disease progression.

Our Managing Partner Sergey Jakimov dove into this topic on the latest episode of the EUVC | The European VC podcast. In short, we invest in startups across biotech and longevity that transforming our lives by helping to prevent, diagnose and treat diseases.

Sergey shared his experience in the field and gave some tips for startups and VCs in the space, tune into the full episode for more.